{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T09:34:00Z","timestamp":1774517640896,"version":"3.50.1"},"reference-count":64,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":2965,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004328","name":"Genentech, Inc","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.jpainsymman.2011.03.017","type":"journal-article","created":{"date-parts":[[2011,8,7]],"date-time":"2011-08-07T10:47:43Z","timestamp":1312714063000},"page":"822-838","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Preliminary Assessment of a Neuropathic Pain Treatment and Referral Algorithm for Patients With Cancer"],"prefix":"10.1016","volume":"42","author":[{"given":"Ellen M. Lavoie","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie A.","family":"Bakitas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Homel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Piehl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Kingman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilo E.","family":"Fadul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilyn","family":"Bookbinder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2011.03.017_bib1","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/S0885-3924(03)00064-2","article-title":"Diagnosis and treatment of neuropathic pain","volume":"25","author":"Chong","year":"2003","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib2","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0733-8619(05)70102-X","article-title":"Neuropathic pain in the cancer patient","volume":"16","author":"Allen","year":"1998","journal-title":"Neurol Clin"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib3","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/00130404-200609000-00002","article-title":"Difficult pain syndromes: bone pain, visceral pain, and neuropathic pain","volume":"12","author":"Shaiova","year":"2006","journal-title":"Cancer J"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib4","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.pain.2008.03.002","article-title":"Incidence rates and treatment of neuropathic pain conditions in the general population","volume":"137","author":"Dieleman","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib5","first-page":"107","article-title":"Mechanisms and management of neuropathic pain in cancer","volume":"1","author":"Paice","year":"2003","journal-title":"J\u00a0Support Oncol"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib6","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0885-3924(00)00183-4","article-title":"Course of symptoms and quality of life measurement in complex regional pain syndrome: a pilot survey","volume":"20","author":"Galer","year":"2000","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/08858190902854715","article-title":"Using quality improvement methodology to improve neuropathic pain screening and assessment in patients with cancer","volume":"24","author":"Smith","year":"2009","journal-title":"J\u00a0Cancer Educ"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib8","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/sonu.2002.30043","article-title":"Quality improvement of painful peripheral neuropathy","volume":"18","author":"Smith","year":"2002","journal-title":"Semin Oncol Nurs"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib9","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/01.NNR.0000289503.22414.79","article-title":"Background noise: the experience of chemotherapy-induced peripheral neuropathy","volume":"56","author":"Bakitas","year":"2007","journal-title":"Nurs Res"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00131402-200112000-00002","article-title":"Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy","volume":"3","author":"Simpson","year":"2001","journal-title":"J\u00a0Clin Neuromuscul Dis"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib11","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0140-6736(09)61081-3","article-title":"Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomized controlled crossover trial","volume":"374","author":"Gilron","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib12","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJMoa042580","article-title":"Morphine, gabapentin, or their combination for neuropathic pain","volume":"352","author":"Gilron","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib13","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.pain.2006.10.029","article-title":"Morphine, nortriptyline and their combination vs. placebo in patients with chronic lumbar root pain","volume":"130","author":"Khoromi","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib14","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/00002508-200009000-00002","article-title":"Amitriptyline and fluphenazine in the treatment of postherpetic neuralgia","volume":"16","author":"Graff-Radford","year":"2000","journal-title":"Clin J Pain"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib15","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/00004691-199701000-00002","article-title":"Neuroanatomy of the pain system and of the pathways that modulate pain","volume":"14","author":"Willis","year":"1997","journal-title":"J\u00a0Clin Neurophysiol"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib16","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0301-0082(92)90027-C","article-title":"Peripheral and central mechanisms of cutaneous hyperalgesia","volume":"38","author":"Treede","year":"1992","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0022-3999(99)00076-8","article-title":"Psychiatric symptoms and distress differ between patients with postherpetic neuralgia and peripheral vestibular disease","volume":"48","author":"Clark","year":"2000","journal-title":"J\u00a0Psychosom Res"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib18","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jpainsymman.2005.04.009","article-title":"Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep","volume":"30","author":"Gore","year":"2005","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib19","first-page":"892","article-title":"Burden of illness in painful diabetic peripheral neuropathy: the patients' perspectives","volume":"7","author":"Gore","year":"2006","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib20","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jpainsymman.2007.12.012","article-title":"Does pain mediate the pain interference with sleep problem in chronic pain? Findings from studies for management of diabetic peripheral neuropathic pain with duloxetine","volume":"36","author":"Fishbain","year":"2008","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib21","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/08870449008400392","article-title":"A\u00a0standardized scale to measure beliefs about controlling pain (BPCQ): a preliminary study","volume":"4","author":"Skevington","year":"1990","journal-title":"Psychol Health"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib22","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0304-3959(98)00220-6","article-title":"Self efficacy as a mediator of the relationship between pain intensity, disability and depression in chronic pain patients","volume":"80","author":"Arnstein","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1300\/J094v04n04_14","article-title":"Psychological aspects of chronic pain and disability","volume":"4","author":"Turk","year":"1996","journal-title":"J Musculoskelet Pain"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0304-3959(94)90049-3","article-title":"Pain beliefs: assessment and utility","volume":"59","author":"Williams","year":"1994","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib25","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0304-3959(93)90165-L","article-title":"Patient-related barriers to management of cancer pain","volume":"52","author":"Ward","year":"1993","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib26","first-page":"312","article-title":"Gender differences in risk factors for aberrant prescription opioid use","volume":"11","author":"Jamison","year":"2010","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib27","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.tig.2007.09.004","article-title":"Genetic architecture of human pain perception","volume":"23","author":"Diatchenko","year":"2007","journal-title":"Trends Genet"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib28","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.pain.2006.05.024","article-title":"Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli","volume":"125","author":"Diatchenko","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib29","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/hmg\/ddi013","article-title":"Genetic basis for individual variations in pain perception and the development of a chronic pain condition","volume":"14","author":"Diatchenko","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.pain.2005.03.032","article-title":"The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients","volume":"116","author":"Rakvag","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib31","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00002508-200209000-00004","article-title":"The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale","volume":"18","author":"Galer","year":"2002","journal-title":"Clin J Pain"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib32","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0149-2918(04)90171-3","article-title":"A\u00a0treatment algorithm for neuropathic pain","volume":"26","author":"Namaka","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib33","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S1474-4422(10)70143-5","article-title":"Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment","volume":"9","author":"Baron","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib34","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/0091270002239817","article-title":"Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature","volume":"43","author":"Gammaitoni","year":"2003","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib35","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0304-3959(03)00317-8","article-title":"Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study","volume":"106","author":"Meier","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib36","first-page":"CD001133","article-title":"Anticonvulsant drugs for acute and chronic pain","volume":"3","author":"Wiffen","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib37","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0885-3924(00)00218-9","article-title":"Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review","volume":"20","author":"Collins","year":"2000","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib38","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1200\/JCO.2004.08.141","article-title":"Gabapentin for neuropathic cancer pain: a randomized controlled trial from the gabapentin cancer pain study group","volume":"22","author":"Caraceni","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib39","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1089\/jpm.2005.8.1118","article-title":"Gabapentin is effective in the treatment of cancer-related neuropathic pain: a prospective, open-label study","volume":"8","author":"Ross","year":"2005","journal-title":"J\u00a0Palliat Med"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib40","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1097\/00002508-200006001-00009","article-title":"The treatment of neuropathic pain: antidepressants and opioids","volume":"16","author":"Watson","year":"2000","journal-title":"Clin J Pain"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib41","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1212\/WNL.50.6.1837","article-title":"Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia","volume":"50","author":"Watson","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib42","first-page":"CD003726","article-title":"Tramadol for neuropathic pain","volume":"2","author":"Duhmke","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib43","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1001\/archneur.60.11.1524","article-title":"Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations","volume":"60","author":"Dworkin","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib44","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0304-3959(99)00154-2","article-title":"Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action","volume":"83","author":"Sindrup","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib45","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1200\/JCO.1998.16.10.3222","article-title":"Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain","volume":"16","author":"Bruera","year":"1998","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib46","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5055\/jom.2006.0040","article-title":"Methadone for cancer-related neuropathic pain: a review of the literature","volume":"2","author":"Mannino","year":"2006","journal-title":"J\u00a0Opioid Manag"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib47","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1200\/JCO.2004.03.172","article-title":"Methadone versus morphine as a first-line strong opioid for cancer pain: randomized, double-blind study","volume":"22","author":"Bruera","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.jpainsymman.2011.03.017_bib48","first-page":"CD003971","article-title":"Methadone for cancer pain","volume":"2","author":"Nicholson","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib49","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pain.2005.03.029","article-title":"Duloxetine vs. placebo in patients with painful diabetic neuropathy","volume":"116","author":"Goldstein","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib50","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1526-4637.2006.00207.x","article-title":"Duloxetine for patients with diabetic peripheral neuropathic pain: a 6-month open-label safety study","volume":"7","author":"Raskin","year":"2006","journal-title":"Pain Med"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib51","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.pain.2005.02.032","article-title":"Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomized, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens","volume":"115","author":"Freynhagen","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib52","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1212\/01.WNL.0000055433.55136.55","article-title":"Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial","volume":"60","author":"Dworkin","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib53","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0304-3959(96)03140-5","article-title":"A\u00a0systematic review of antidepressants in neuropathic pain","volume":"68","author":"McQuay","year":"1996","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib54","first-page":"CD005454","article-title":"Antidepressants for neuropathic pain","volume":"4","author":"Saarto","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib55","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3109\/07853890008995932","article-title":"Evidence-based data on pain relief with antidepressants","volume":"32","author":"Fishbain","year":"2000","journal-title":"Ann Med"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib56","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0304-3959(02)00047-7","article-title":"Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy","volume":"98","author":"Hammack","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib57","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pain.2007.08.033","article-title":"Pharmacologic management of neuropathic pain: evidence-based recommendations","volume":"132","author":"Dworkin","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib58","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.pain.2005.08.013","article-title":"Algorithm for neuropathic pain treatment: an evidence based proposal","volume":"118","author":"Finnerup","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib59","doi-asserted-by":"crossref","first-page":"885","DOI":"10.4140\/TCP.n.2009.885","article-title":"A\u00a0treatment algorithm for neuropathic pain: an update","volume":"24","author":"Namaka","year":"2009","journal-title":"Consult Pharm"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib60","series-title":"Advances in Pain Research and Therapy: Issues in Pain Measurement","first-page":"391","article-title":"Measurement of pain by subjective report","author":"Cleeland","year":"1989"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib61","unstructured":"Cleeland CS. The Brief Pain Inventory User Guide. Available from http:\/\/www.mdanderson.org\/education-and-research\/departments-programs-and-labs\/departments-and-divisions\/symptom-research\/symptom-assessment-tools\/BPI_UserGuide.pdf. Accessed July 28, 2009."},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib62","unstructured":"The Brief Pain Inventory. Available from http:\/\/www.mdanderson.org\/education-and-research\/departments-programs-and-labs\/departments-and-divisions\/symptom-research\/symptom-assessment-tools\/brief-pain-inventory.html. Accessed July 28, 2009."},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib63","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1200\/JCO.1993.11.11.2081","article-title":"Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer","volume":"11","author":"Kornblith","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2011.03.017_bib64","volume":"Vol. VIII","author":"Brook","year":"1979"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392411002661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392411002661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:06:39Z","timestamp":1760130399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392411002661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":64,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0885392411002661"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2011.03.017","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preliminary Assessment of a Neuropathic Pain Treatment and Referral Algorithm for Patients With Cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2011.03.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}